Myriocin Treatment Reverses Alcohol-Induced Alterations in Polyunsaturated Fatty Acid-Containing Phospholipid Expression in the Liver

Chronic heavy alcohol exposure causes steatohepatitis manifested by abnormal intra-hepatocyte accumulation of lipid and parenchymal inflammation. Attendant alterations in polyunsaturated fatty acid (PUFA)-containing phospholipids could cause alcoholic liver disease (ALD) to progress by promoting oxidative stress, inflammation, and fibrogenesis. Previously we showed that myriocin. a serine palmitoyltransferase inhibitor, ameliorates experimental alcohol-induced steatohepatitis. However. the surprising overall therapeutic responses suggested that myriocin's targets may go beyond sphingolipids. To this end, the present study examines the effects of myriocin on hepatic composition of docosahexaenoic acid (DHA)- and arachidonic acid (AA)-containing phospholipids in an experimental model of ALD. A chronic+ binge ethanol exposure model was generated by feeding Long Evans rats with ethanol-containing diets (24% caloric content) for 8 weeks and simultaneously binge gavage administering 2 g/kg ethanol on Tuesdays. Thursdays and Saturdays during Weeks 6-8. Myriocin was administered by i.p. injection on Mondays. Wednesdays. and Fridays of Weeks 3-8. Control rats were studied in parallel. Upon euthanasia, the livers were harvested to examine ethanol- and/or myriocin-modulation of hepatic lipids using matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDIIMS). Results were analyzed statistically by two-way analysis of variance and depicted with data bar plots and heatmaps. Chronic+ binge ethanol exposures significantly increased hepatic expression of AA-containing phospholipids including PE(36:4) (P= .005). PE(38:4) (P=.03), and PI(38:4) (P=.04) and reduced DHA-containing phospholipids including PS(40:6) (P= .03) and PE(40:6) (P= .04) relative to control. Myriocin partially reversed ethanol's effects on hepatic PUFA expression by decreasing PE(36:4) (P= .004) and increasing PS(40:6) (P= .04) and PI(40:6) (P= .0003) relative to ethanol-exposed rats. Ethanol-mediated alterations in hepatic PUFA-containing phospholipids may contribute to hepatic oxidative and inflammatory injury by increasing AA and fibrogenesis by inhibiting DHA. The results suggest that Myriocin may help reduce or prevent long-term and progressive liver injury stemming from excessive chronic+binge ethanol consumption.

Automated summary

Chronic heavy alcohol exposure can cause alcoholic liver disease, but it can be improved by using the serine palmitoyltransferase inhibitor myriocin, which may regulate the composition of hepatic phospholipids containing docosahexaenoic acid and arachidonic acid.